Wang, Ge <br/><br/>
Toosendanin suppresses oncogenic phenotypes of human gastric carcinoma SGC‑7901 cells partly via miR‑200a‑mediated downregulation of β-catenin pathway.  [electronic resource] 

 -  International journal of oncology  Nov 2017 
 - 1563-1573 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1791-2423 
<br/><br/><label>Standard No.: </label>10.3892/ijo.2017.4139  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Carcinoma--drug therapy<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Drugs, Chinese Herbal--administration & dosage<br/>Epithelial-Mesenchymal Transition--drug effects<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Mice<br/>MicroRNAs--genetics<br/>Neoplasm Invasiveness--genetics<br/>Neoplasm Metastasis<br/>Stomach Neoplasms--drug therapy<br/>Wnt Signaling Pathway--drug effects<br/>Xenograft Model Antitumor Assays<br/>beta Catenin--genetics